[Adrenergic alpha-receptor blockaders and direct arteriolar vasodilators in treatment of chronic cardiac insufficiency].
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D001160:Arterioles / Q000503:physiopathology; D002303:Cardiac Output, Low / Q000188:drug therapy* / Q000503:physiopathology; D002908:Chronic Disease; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D010646:Phentolamine / Q000627:therapeutic use; D011224:Prazosin / Q000627:therapeutic use; D014326:Tropanes / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use*
D000317:Adrenergic alpha-Antagonists; D014326:Tropanes; D014665:Vasodilator Agents; D006830:Hydralazine; C009599:tropodifene; D011224:Prazosin; D010646:Phentolamine
Blokatory al'fa-adrenergicheskikh retseptorov i arterioliarnye vazodiliatory pripamogo deĭstviia pri lechenii khronicheskoĭ serdechnoĭ nedostatochnosti.